StonvexLoading…
StonvexStonvexStonvexCore line items from SRXH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-12-31 | Annual 2024 2024-06-01 | Annual 2023 2023-12-31 |
|---|---|---|---|---|
Revenue | $6.53M | $34.98M | $2.00M | $38.59M |
Operating Income | $-11.41M | $-5.97M | Not available | $-21.18M |
Net Income | $-45.01M | $-168.00K | Not available | $-22.77M |
EPS (Diluted) | $-2.13 | $-0.10 | Not available | $-32.29 |
Total Assets | $8.40M | $15.80M | Not available | $16.74M |
Total Liabilities | $8.00M | $7.15M | Not available | $13.76M |
Cash & Equivalents | $1.31M | $3.07M | Not available | $4.46M |
Free Cash Flow OCF − CapEx | Not available | $-4.40M | Not available | $79.00K |
Shares Outstanding | 24.92M | 1.83M | Not available | 729.03K |